A biomarker for categorising colorectal cancer patients

Press/Media: Press / Media

View graph of relations


Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths worldwide. While endoscopic submucosal dissection (ESD), a minimally invasive surgical procedure to remove gastrointestinal tumours, is sufficient for treating early-stage CRC patients who are at low risk for developing lymph-node metastasis (LNM), the current risk-stratification criteria based on post-endoscopic pathological examination tend to overestimate the degree of risk. A new biomarker was developed by a joint research team to detect LNM in patients with T1 CRC more accurately.
Period28 Mar 2019

Media coverage

TitleA biomarker for categorising colorectal cancer patients
Media name/outletCity University of Hong Kong - Research Stories
PlaceHong Kong
Media typeWeb